Transgene-Free Disease-Specific Induced Pluripotent Stem Cells from Patients with Type 1 and Type 2 Diabetes

The induced pluripotent stem cell (iPSC) technology enables derivation of patient-specific pluripotent stem cells from adult somatic cells without using an embryonic cell source. Redifferentiation of iPSCs from diabetic patients into pancreatic islets will allow patient-specific disease modeling and...

Full description

Saved in:
Bibliographic Details
Main Authors: Kudva, Yogish C., Ohmine, Seiga, Greder, Lucas V., Dutton, James R., Armstrong, Adam, De Lamo, Josep Genebriera, Khan, Yulia Krotova, Thatava, Tayaramma, Hasegawa, Mamoru, Fusaki, Noemi, Slack, Jonathan M.W., Ikeda, Yasuhiro
Format: Artigo
Language:Inglês
Published: AlphaMed Press 2012
Subjects:
Embryonic Stem Cells/Induced Pluripotent Stem (iPS) Cells
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3652675/
https://ncbi.nlm.nih.gov/pubmed/23197849
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5966/sctm.2011-0044
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items